Incoming Cardiology Fellow @LVHN | PGY-3 Resident Physician @CookCountyIMR | Computational Cardiology | Research Enthusiast | Insta: @doctor_kumarr

Chicago, IL
Joined July 2021
Stay tuned for my full interview with @chadialraies on presentation and prevalence of coronary in-stent restenosis and how do the management strategies, i,e drug coated balloons and drug eluting stents compare with each other. Check out the full length manuscript in the American Journal of Cardiology. doi.org/10.1016/j.amjcard.20… @cvinnovations @AmJCardio @ACCmediacenter @ACCinTouch @American_Heart #CardioTwitter #Cardiology #CardioEd #CVI2024
3
4
1
56
10,472
Manoj Kumar, M.D. retweeted
There coming!!!
A novel low-profile (10F) percutaneous LV support device with up to 5.5 L/min demonstrates favorable performance and device-related safety in an early high-risk PCI feasibility study. The SUPPORT I Study. @azeemlatib @Kandzari ahajrnls.org/3QVIyzX
1
6
63
9,979
Manoj Kumar, M.D. retweeted
The 🆕 2026 Guideline for Management of Dyslipidemia, released by @ACCinTouch @AHAScience @ASPCardio @nationallipid chaired by Drs @rblument1 & @PamelaBMorris, is up at AHA #EPILifestyle26 today. 🔍A deep dive here: youtu.be/yHXL_dH8zCo
Key updates to this guideline include: ➡️ The use of the American Heart Association PREVENT-ASCVD equations to guide primary-prevention and lipid-lowering therapy decisions. ➡️ Testing Lp(a) at least once in a lifetime and selective apolipoprotein B measurement to improve risk assessment and guide treatment ➡️ The return of LDL-C and non-high-density lipoprotein cholesterol treatment goals (with lower targets for higher-risk groups) ➡️ Expanded use of coronary artery calcium scoring to reclassify risk[ME1.1] ✍🏼 @rblument1 @tygluckman @RonBlankstein @PamelaBMorris @pnatarajanmd @AnnMarieNavar @SethShayMartin @APRN_CNS @nyulangone @DrMichaelShapir @kgradneyrd @eugeniagianos @virani_md @KellieMcLain1 @ijeomaheartdoc @SamiaMoraMD @DrHeatherJohn @dmljmd
1
5
26
2,763
Manoj Kumar, M.D. retweeted
RIP Dr. Amir Lerman. May his memory be a blessing.
Prof. @LermanAmir , a world authority on coronary microvascular dysfunction and my mentor at @MayoClinicCV , passed away today. He shaped my thinking as a physician and scientist, and I was fortunate to also call him a close friend. His scientific and human legacy will endure.
3
12
48
7,050
Manoj Kumar, M.D. retweeted
The 🆕 2026 Guideline for Acute Pulmonary Embolism🫀in Adults, just released by @ACCinTouch @AHAScience @SCAI @ACEPNation @accpchest @SVM_tweets chaired by @DrMarkCreager @jaygirimd @GBarnesMD 🔍A deep dive here: 🎥youtu.be/rE-I4Jwq1UA – at West Hollywood, CA
ICYMI: 🆕 ACC/AHA/Multisociety Guideline for the Evaluation & Management of Acute PE in Adults is a de novo document offering comprehensive, evidence‑based recommendations for the evaluation, mgmt & follow‑up of adults w/ acute PE. Get the details: jacc.org/doi/10.1016/j.jacc.… #JACC
16
43
5,904
Manoj Kumar, M.D. retweeted
Music of the Heart 🫀🎶🎵: Tune in to my talk/live performance at the 23rd annual Controversies and Advances in the Treatment of Cardiovascular Disease 🔗youtube.com/watch?v=-OxiLOLn… @SmidtHeart @CedarsCards @hmkyale @aakriti_15 – at Beverly Hills, CA
4
27
1,340
Manoj Kumar, M.D. retweeted
Dr @RajMakkarMD on "Top 10 Lessons Learned in Almost 20 Years of #TAVR" @SmidtHeart – at Beverly Hills, CA
1
1
24
2,052
Manoj Kumar, M.D. retweeted
Introducing the percutaneous aorto-coronary bypass graft. The VECTOR procedure revascularizes the left main coronary artery using retrograde and antegrade steps: a retrograde wire exits the left main (distal graft), an electrosurgical wire exits the aortic root (proximal graft), a guidewire rail is created, and a stent graft is delivered from the aorta to the left main. What could possibly go wrong? ahajournals.org/doi/10.1161/…
28
194
29
688
111,723
Manoj Kumar, M.D. retweeted
If you cannot explain something in simple terms, you don't understand it.
78
382
30
2,244
89,191
From Abstract Presenter to Reviewer. I'm truly honored to be invited as an Abstract and Case Reviewer for ACC.26. It’s incredibly fulfilling to transition from submitting my own work to now contributing to the selection of the best science and research in cardiovascular medicine. Grateful to the ACC Program Committee for this opportunity. Looking forward to reviewing cutting-edge submissions and supporting the advancement of global cardiovascular innovation. #ACC @ACCinTouch @JACCJournals
4
1
64
5,114
1/ It’s #July!! Welcome aboard new fellows! Over the next few days I’ll post things that will be helpful as you start your training! To start- a #XTutorial on CATH LAB VIEWS! 🔑 LAO- left/right 🔑 RAO- ant/post 🔑 Cranial- distal 🔑 Caudal- proximal #CardioX @RadialFirstBot
4
26
2
133
10,399
In our post hoc analysis of the randomized STEP trial, ARBs and CCBs appeared more favorable for reducing composite cardiovascular outcomes than diuretics and beta-blockers. Full article here (open access): bmcmedicine.biomedcentral.co… @CTCPR_ @RigsHeart
2
6
412
Thrilled to receive the Hirsch Travel Grant from Society of Vascular Medicine! Grateful for the opportunity and excited to join everyone in Philly! @LVHNCardiology @LVHN
3
29
1,973
Day 2 at #NYValves2025 did not disappoint! 🎉Cutting-edge late-breaking science, live cases, and vibrant networking filled the halls. Swipe through these moments capturing the passion and progress driving our field forward! 🚀 #CardioX #CardioTwitter #CardioEd #CardioResearch @jgranadacrf @MartyBLeon @bapat_savrtavr @djc795 @samdawkins @npfam1 @AdamGreenbaumMD @hahn_rt @azeemlatib @TheDoctorMack @modine_thomas @tnazifMD @PopmaJeffrey @drnvanmieghem @PradeepYadavMD @mirvatalasnag @triciarawh @TCTConference @TCTMD @sbhci
2
12
37
2,604
The energy is high and #NYValves2025 is in full swing! 🙌 All theaters are buzzing with world-class education, live cases, and groundbreaking science.
1
8
2
40
3,612
🚀 Whether you’re just starting with #LAAC or looking to refine advanced skills, the LAAC Summit at #NYValves2025 delivers expert-driven insights for every stage of practice. This is why @SDoshiMD calls it a must for all experience levels. 🔗ow.ly/F0lX50W9jse #CardioX
1
12
1
14
1,822
Manoj Kumar, M.D. retweeted
📚Revascularization Strategies for #MultivesselDisease in #AcuteCoronarySyndrome: 🔍 Key Takeaways: ✅ Complete Index Procedure (CIP) & Complete Stage Procedure (CSP) lowers the need for future revascularization ✅ CSP lowers cardiac death ✅ CIP lowers recurrent #MI 🚫 No increase in bleeding, stroke, or mortality ➡️doi.org/10.1016/j.jscai.2024… @KhHarmouch @dr_hamza_md @NomeshKumar_MD @ZarghoonaWajid @NPatelMDc @MasoomaNaseemMD @PrakashUpretiMD @KumarManoj_MD @vakasullah @DryasarsattarMD @timir_paul @esbrilakis @chadialraies
6
1
17
2,258